Monday, November 16, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Health

Final e-pharmacies rules expected in 2020

Fiinews by Fiinews
January 2, 2020
in Health, Investment, Manufacturing
Reading Time: 2 mins read
A A
0
PGD 15 FII Ad Mix Stack
0
SHARES
16
VIEWS
LinkedinShare on Twitter

Manufacturers must use new brand names

 

CDSCO

A final set of rules is expected this year on how e-pharmacies should be properly regulated, according to Nishith Desai Associates (NDA) which reviewed the industry in 2019.

“All in all, the progress made over the course of 2019 has paved the way for a very exciting 2020!” said the Mumbai headquartered global consultancy.

The government has also taken some laudatory steps by requiring manufacturers to use brand names for drugs that are not similar to other brand names or trade names of drugs already in existence as a condition for obtaining the manufacturing license, it noted.

Given all the collective developments that have taken place in 2019, 2020 should be filled exciting times for the pharma industry. In case you missed it, do also read our pharma round up covering updates from January to July here.

The Drug Controller General of India (DCGI) has issued an office letter on 28 November 2019 requiring all drug controllers to enforce an order passed by the Delhi High Court in December 2018 in the case of Zaheer Ahmed v. Union of India W.P.(C) 11711/2018 (Delhi HC Order) which prohibited the online sales of medicines without a valid license (Office Letter).

The Delhi HC Order is based on a previous order issued by the Madras High Court banning the online sales of medicine altogether. However, even though the Madras High Court Order was subsequently reversed in appeal, the Delhi HC Order continues to remain in force.

The Office Letter is the latest development in a series of events surrounding e-pharmacy regulation.

According to NDA, e-Pharmacies have been at the center of controversy in India since 2015, with regulators being asked to keep a strict watch on all players in the market until the expert committee, headed by ex-Maharashtra Food and Drug Commissioner Harshdeep Kamble examined the issues in the sector.

The committee had later submitted its recommendations to DCGI, India’s apex drug regulator, who had reportedly examined the report and forwarded his recommendations to the Ministry of Health and Family Welfare.

Subsequently, in August 2018, the Health Ministry released draft rules proposing to regulate e-pharmacies under the ambit of D&C Act (E-pharmacy Rules).

However, soon after the E-pharmacy Rules were published the aforementioned orders were passed by the Delhi High Court and Madras High Court.

The Office Letter appears to only be a continuation and reaffirmation of the current position i.e. online sale of medicines should not be done by pharmacies who are not licensed. fiinews.com

Tags: Ministry of Health and Family WelfareNishith Desai Associates
ShareTweetShare

Related Posts

Vikram Solar
Manufacturing

Manufacture: TN facility to produce from Dec 2026

by Fiinews
November 16, 2026
0
10

Vikram to be fully integrated solar manufacturer Kolkata-headquartered Vikram Solar Limited says its 9-GW N-type TOPCon cell facility at Gangaikondan,...

ISNT
Manufacturing

Manufacture: Minister wants a strengthened NDT ecosystem

by Fiinews
November 16, 2026
0
17

Public Sector Undertakings, private manufacturers, start-ups and MSMEs have important role to play defence technology Defence Minister Rajnath Singh has...

Singapore Exchange

Invest: UTI Nifty listed in Singapore

November 14, 2026
19
NITI Aayog

Manufacture: PLI successful, says NITI Aayog

November 14, 2026
16
Zetsol

Manufacture: 22 bids received for ACC facilities

November 14, 2026
21
A7

Invest: A7 expands cross-border payment in India

November 12, 2026
22
SBI YONO

Recent News

  • Manufacture: TN facility to produce from Dec 2026
  • Market: Hanon reinforced commitment to India
  • Project: PM dedicates Bengaluru terminal to nation
  • Manufacture: Minister wants a strengthened NDT ecosystem
  • Tech: Joshi’s call “think beyond boundaries”

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.